• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Certara updates PK/PD Phoenix Software

Certara updates PK/PD Phoenix Software

August 10, 2016
CenterWatch Staff

Certara, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has announced the launch of Phoenix 7.0. Phoenix is the most advanced, intuitive, and widely-used software for pharmacokinetic (PK), pharmacodynamic (PD), and toxicokinetic (TK) modeling and simulation.

Phoenix is used by 6,000 researchers at 1,500 biopharmaceutical companies and 200 academic institutions in 60 countries. Phoenix is also employed by many global regulatory agencies for submittal review, including seven divisions of the FDA.

“PK/PD modeling and simulation has played an increasingly important role in the drug development process since its inception 30 years ago, and it is now used in more than 90% of new drug and biologics approvals,” said Certara CEO Edmundo Muniz, M.D., Ph.D. “We are proud to be leading the industry and leveraging the largest and most advanced modeling and simulation technology and consulting portfolio. Phoenix 7.0 affirms our commitment to maintaining that preeminent position, delivering cutting-edge technology to the global drug development community.”

New features and enhancements in Phoenix 7.0 include:

  • A new graphics engine, which generates publication-quality images right out of the box, eliminating the need for third-party graphing tools.
  • A new data layer that uses 90% less memory and greatly improves the user experience when working with large datasets or modeling projects.
  • Integrated parallel computing technology, which cuts non-compartmental analysis (NCA) time by 50%.
  • Support for executing Phoenix NLME jobs on remote/parallel computing platforms right from the desktop application.
  • Integration in a PK/PD modeling language of delay differential equations, which is a particularly important technique in complex therapeutic areas such as oncology, diabetes and arthritis.

“We are committed to developing the most scientifically advanced and easiest-to-use software for drug development scientists,” said Nathan Teuscher, Ph.D., Certara’s vice president of pharmacometric solutions. “We incorporate best practices gleaned from our customers, colleagues at Certara Strategic Consulting, academic centers of excellence, and regulatory agency partners into Phoenix to make PK/PD analysis easier and more efficient. We are excited to release this powerful new set of features in Phoenix 7.0 to the global drug development community to help scientists in their efforts to develop life-saving medicines for patients.”

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing